Stockhub

Mabion S.A.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 September 2022

  • curprev 07:2307:23, 26 September 2022‎ 95.149.241.133 talk‎ 509 bytes +509‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland. == References and notes..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Mabion_S.A.’